Here's another reason to hate leftovers. A research study appearing in the April 2009 issue of the Journal of Leukocyte Biology (http://www.
"Despite recent advances in the treatment of arthritis, none target its cause," said Michael Davey, Associate Chief of Staff for Research at the Portland Oregon Veteran's Affairs Medical Center and one of the researchers involved in the study. "Our work with MDP and NOD2 is a step toward understanding the root cause of arthritis which one day may allow certain forms of arthritis to be prevented altogether."
Davey and colleagues made this discovery through experiments using two groups of mice, one group was normal and the other had been genetically modified so that their NOD2 gene was deactivated (commonly referred to as "knocked out"). Then they administered MDP to the joints of mice in each group, and unlike the normal group of mice, the mice with the deactivated NOD2 gene did not experience signs of arthritis. This may also be an important advance in the understanding and treatment of Blau Syndrome, a rare genetic disease characterized by granulomatous arthritis (arthritis caused by bacteria), uveitis (inflammation in the middle layer of the eye), skin rash and cranial neuropathy (a disorder affecting nerves that control sight, eye movement, hearing, and taste).
"Now that we know that bacterial products can activate this NOD2 pathway and that this signal contributes to arthritis," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology, "the next step is to find treatments that either rid the body of this inflammatory signal or mask it. Either way, the net effect would be the same: people would be spared from a very crippling disease. "
According to the U.S Centers for Disease Control and Prevention more that 40 million American say that they have been told by a doctor that they have arthritis or another rheumatic condition. Arthritis is the most common cause of disability in the United States and limits activities of nearly 19 million people.
The Journal of Leukocyte Biology (http://www.jleukbio.org) publishes peer-reviewed manuscripts on original investigations focusing on the cellular and molecular biology of leukocytes and on the origins, the developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes and other cells involved in host defense and inflammation. The Journal of Leukocyte Biology is published by the Society for Leukocyte Biology.
Article Details: H. L. Rosenzweig, M. M. Jann, T. T. Glant, T. M. Martin, S. R. Planck, W. van Eden, P. J. S. van Kooten, R. A. Flavell, K. S. Kobayashi, J. T. Rosenbaum, and M. P. Davey. Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis. J Leukoc Biol 2009 85: 711�. http://www.